None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects who informed consent Age 20-70 years Smoker (smoking = 1 year and = 10 cigarettes)
Exclusion criteria
Exclusion criteria: BMI = 18.5kg/m2 or BMI = 35kg/m2 Body weight fluctuation of 10% or more in the past 8weeks Excessive activity Takes hormone therapy (female) Drinking alcohol more than 140g/week Platelet function disorder Taking anti-platelet medication (aspirin, antiplatelet agent, non-steroidal anti-inflammatory drugs) Cardiovascular or haematological disorders, insulin resistance, diagnosed non-insulin dependent diabetes disease (Cardiovascular disease, heart failure, myocardial infarction, cerebrovascular disease, arteriosclerosis, diabetes, thyroid abnormality, ulcer, gastric bleeding, infectious diseases, systemic inflammatory diseases, acute inflammation, malignancy, renal disease, renal function, liver disease, lung disease, blood coagulopathy) Take oriental medicine or other medicine and functional foods continuously in the 4 weeks Subjects who have hypersensitivity about test material Participate other human study in the 12 weeks Pregnat woman or lactating woman Subjects who unsuiable about this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation test | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood flow | — |
Countries
Korea, Republic of
Contacts
Ewha Womans University